Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 0.04%.

  • OptimizeRx's Return on Capital Employed rose 2300.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.09% for FY2024, which is 1000.0% up from last year.
  • OptimizeRx's Return on Capital Employed amounted to 0.04% in Q3 2025, which was up 2300.0% from 0.03% recorded in Q2 2025.
  • Over the past 5 years, OptimizeRx's Return on Capital Employed peaked at 0.04% during Q3 2025, and registered a low of 0.19% during Q4 2023.
  • Over the past 5 years, OptimizeRx's median Return on Capital Employed value was 0.08% (recorded in 2022), while the average stood at 0.08%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -1000bps in 2022, then surged by 2300bps in 2025.
  • Quarter analysis of 5 years shows OptimizeRx's Return on Capital Employed stood at 0.0% in 2021, then crashed by -3546bps to 0.1% in 2022, then plummeted by -100bps to 0.19% in 2023, then skyrocketed by 53bps to 0.09% in 2024, then skyrocketed by 149bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q3 2025, 0.03% for Q2 2025, and 0.07% during Q1 2025.